Biochemistry, Genetics and Molecular Biology
Programmed Cell Death
100%
Androgen Receptor
99%
RE1-silencing Transcription Factor
49%
Corepressor
40%
Transactivation
39%
Ligand Binding
34%
Agonist
33%
Cancer Cell
31%
Polymorphonuclear Cell
24%
DNA Binding
24%
Binding Domain
24%
Messenger RNA
24%
Transcriptional Repressor
24%
Doxorubicin
24%
Immunoglobulin Domain
24%
Cell Death
24%
Fas Ligand
24%
Retinoic Acid Receptor
24%
Amino Acid Substitution
24%
Histone Methylation
24%
Mouse Model
24%
Epidermal Growth Factor Receptor
24%
Nucleolin
24%
Nuclear Matrix
24%
Histone Deacetylase 2
24%
Human Herpesvirus 8
24%
Fas Receptor
20%
Protein L
19%
Promyelocytic Leukemia Protein
19%
Caspase
18%
Sonic Hedgehog
17%
Untranslated Region
16%
Ribonucleoprotein
16%
B Cell
15%
Histone
14%
ErbB
14%
Bimolecular Fluorescence Complementation
14%
Dimerization
14%
Downregulation
13%
Wild Type
12%
Methylation
12%
Flow Cytometry
12%
Hepatocyte
10%
CDKN1B
9%
GLI1
9%
N-Terminus
8%
Translational Regulation
8%
R-Factor
8%
Hydrodynamics Based Transfection
8%
RNA Translation
8%
Keyphrases
Zinc Finger Protein
74%
Androgen Receptor
74%
Medulloblastoma
63%
Fluorine-19 MRI
49%
Corepressor
34%
Transactivation
29%
Transcriptional Repressor
27%
Apoptosis
27%
Intranuclear
26%
Treatment Decisions
24%
Doxorubicin
24%
TIF2
24%
PTCH1
24%
Histone Deacetylase 2 (HDAC2)
24%
Mouse Model
24%
Chromatin Compaction
24%
Opposite Effects
24%
Splice Variant
24%
Fas Expression
24%
Akt Activation
24%
Tumor Biology
24%
Patient Outcomes
24%
Focus Formation
24%
Hippo-YAP
24%
USP37
24%
Natural Killer Cells
24%
RE1-silencing Transcription Factor
24%
Liver Cancer
24%
Human Antigen R
24%
Milatuzumab
24%
Induced Damage
24%
Current Treatment
16%
Sonic Hedgehog
12%
Tumor
11%
Hepatocellular Carcinoma Cells
11%
Coactivator
10%
Gli1
9%
Resistance to Cell Death
8%
Pediatric Brain Tumor
8%
Transcriptional Activity
8%
Treatment Modalities
8%
Individualized Treatment
8%
Hepatocellular Carcinoma
8%
Tumor-specific
8%
Neurological Sequelae
8%
New Drug Targets
8%
Radiation Dose
8%
High-dose Chemotherapy
8%
Brain Sparing
8%
Endocrine Sequelae
8%
Medicine and Dentistry
Programmed Cell Death
80%
Antigen
24%
Retinoic Acid Receptor
24%
Doxorubicin
24%
Granulocyte
24%
Fas Ligand
24%
Ligand Binding
24%
Liver Cancer
24%
Fluorine
24%
Nucleolin
24%
Medulloblastoma
24%
Tumor Biology
24%
Hepatocellular Carcinoma
22%
Promyelocytic Leukemia Protein
19%
Acute Promyelocytic Leukemia
13%
Recurrent Disease
8%
Pediatric Brain Tumor
8%
Sequela
8%
Carcinoma Cell
8%
Messenger RNA
8%
Tumor Necrosis Factor Receptor Superfamily Member 6
8%
High Dose Chemotherapy
8%
Specific Tumor
8%
Leukemia Cell
5%
Ribonucleoprotein
5%
Death Receptor
5%
Untranslated Region
5%
Fas Antibody
5%
Cell Surface
5%
Hepatocyte
5%